Drugs / Autologous CD4+T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02427776 | Jan 2015 → Aug 2016 | relapsing-remitting multiple sclerosis | Imcyse SA | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous CD4+T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02427776 ↗ |
| Modality | Cell therapy | “Autologous CD4+T cells stimulated and expanded ex vivo” NCT02427776 ↗ |